People: Transition Therapeutics Inc (TTH.TO)
Mr. Michael Richard Dwyer Ashton is Lead Independent Director of Transition Therapeutics Inc. Mr. Ashton has been an independent consultant to the pharmaceutical industry since March 2006. Prior thereto, he was the Chief Executive Officer of SkyePharma PLC. He has 30 years of experience in the Pharmaceutical industry having worked for Merck, Pfizer, Purepac and Faulding, where Mr. Ashton was Chairman, President and CEO. Mr. Ashton currently sits on boards of directors of the following public companies; Hikma Pharmaceuticals PLC, and Proximagen Neuroscience PLC.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|